Hiroyoshi Suzuki

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

Silke Gillessen, Gerhardt Attard, Tomasz M. Beer et al. · European Urology · 2017 · 643 citations · Full text

Medicine, Oncology, Urology +17

Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression

Young E. Whang, Xinyi Wu, Hiroyoshi Suzuki et al. · Proceedings of the National Academy of Sciences · 1998 · 638 citations

Medicine, Molecular Biology, Oncology +16

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Michiel S. van der Heijden, Matthew D. Galsky, Yohann Loriot et al. · The Lancet Oncology · 2020 · 498 citations · Full text

Medicine, Oncology, Pharmacology +14

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

Silke Gillessen, Gerhardt Attard, Tomasz M. Beer et al. · European Urology · 2020 · 395 citations · Full text

Medicine, Oncology, Urology +17

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

Jianfeng Xu, Shusen Zheng, Akira Komiya et al. · Nature Genetics · 2002 · 389 citations

Medicine, Genetics, Molecular Genetics +17